Clenbuterol Hydrochloride: Advanced Bronchodilation and Metabolic Support
| Product dosage: 40mcg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.01 | $40.14 (0%) | 🛒 Add to cart |
| 20 | $3.51 | $80.27 $70.24 (12%) | 🛒 Add to cart |
| 30 | $2.84 | $120.41 $85.29 (29%) | 🛒 Add to cart |
| 60 | $1.89 | $240.82 $113.39 (53%) | 🛒 Add to cart |
| 90 | $1.66 | $361.23 $149.51 (59%) | 🛒 Add to cart |
| 120 | $1.42 | $481.64 $170.58 (65%) | 🛒 Add to cart |
| 180 | $1.35 | $722.46 $243.83 (66%) | 🛒 Add to cart |
| 270 | $1.30 | $1083.68 $352.20 (68%) | 🛒 Add to cart |
| 360 | $1.25
Best per pill | $1444.91 $451.53 (69%) | 🛒 Add to cart |
Synonyms | |||
Clenbuterol Hydrochloride is a potent, selective beta-2 adrenergic receptor agonist primarily developed for the management of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Its mechanism of action involves the relaxation of bronchial smooth muscle, leading to significant improvements in airflow and oxygenation. Beyond its established pulmonary applications, it is also recognized in certain clinical and performance contexts for its ancillary effects on metabolic rate and body composition, though these uses are strictly off-label and subject to significant regulatory and safety considerations. This product card provides a comprehensive, evidence-based overview intended for healthcare professionals and informed users, detailing its pharmacological profile, appropriate use, and critical safety information.
Features
- Active Ingredient: Clenbuterol Hydrochloride
- Chemical Designation: 1-(4-Amino-3,5-dichlorophenyl)-2-(tert-butylamino)ethanol hydrochloride
- Pharmacological Class: Selective beta-2 adrenergic agonist
- Standard Presentation: Tablets, syrup, or injectable solution (availability varies by jurisdiction)
- Typical Strengths: 20 mcg tablets, 0.01% syrup, 30–40 mcg/mL injectable formulations
- Half-Life: Approximately 26–36 hours
- Bioavailability: High oral bioavailability (~80-90%)
- Onset of Action: Within 15–30 minutes (oral administration)
Benefits
- Provides rapid and sustained bronchodilation, improving respiratory function in obstructive airway diseases.
- Enhances alveolar oxygen exchange, reducing the sensation of breathlessness during exertion or acute bronchospasm.
- May increase basal metabolic rate through thermogenic stimulation, though this is not an approved indication.
- Supports maintenance of lean mass in certain catabolic states under clinical supervision (off-label).
- Exhibits a long half-life, allowing for less frequent dosing compared to some short-acting beta-agonists.
- Can be used as a preventive agent in exercise-induced bronchoconstriction when administered prophylactically.
Common use
Clenbuterol is clinically indicated for the treatment and prophylaxis of bronchospasm associated with asthma, bronchitis, and other obstructive pulmonary diseases. It is also used in veterinary medicine for similar respiratory indications. Off-label, it has been utilized in certain performance and body composition contexts due to its perceived metabolic effects, though such use is not medically endorsed and is prohibited in most competitive sports. Its anabolic-like properties in animal studies have led to exploratory use in muscle-wasting conditions, though human data remain limited and such applications are not approved.
Dosage and direction
Dosing must be individualized based on indication, patient response, and tolerance. For bronchial asthma in adults, an initial oral dose of 20–40 mcg per day is typical, which may be adjusted under medical supervision. The maximum daily dose should not exceed 120–160 mcg. Administration is usually oral, with or without food, though timing may be adjusted to align with symptom patterns (e.g., pre-exercise for EIB). Always begin with the lowest effective dose and titrate gradually to minimize side effects. Use beyond 2–3 weeks is generally discouraged without interruption due to receptor downregulation.
Precautions
Use with caution in patients with cardiovascular disorders, hypertension, diabetes, hyperthyroidism, or a history of seizures. Periodic monitoring of heart rate, blood pressure, and electrolyte levels (especially potassium) is advised. Tachyphylaxis may develop with prolonged use; consider drug holidays or alternative therapies. Not recommended for use in pediatric or geriatric populations without strict medical oversight. Avoid abrupt discontinuation after prolonged use.
Contraindications
Hypersensitivity to clenbuterol or any component of the formulation; tachyarrhythmias; severe coronary artery disease; uncontrolled hypertension; hypertrophic cardiomyopathy; pheochromocytoma. Concurrent use with other sympathomimetic agents is contraindicated. Not for use during pregnancy or lactation unless potential benefit justifies potential risk.
Possible side effect
Common side effects may include tachycardia, palpitations, tremors, headache, insomnia, sweating, and muscle cramps. Less frequently, hypertension, hypokalemia, nausea, and dry mouth may occur. Rare but serious adverse effects include cardiac hypertrophy, myocardial ischemia, and arrhythmias—particularly with misuse or overdose. Psychological effects such as anxiety or agitation have been reported.
Drug interaction
May interact with other beta-agonists, MAO inhibitors, tricyclic antidepressants, thyroid hormones, and diuretics (potentiating hypokalemia). Concomitant use with xanthine derivatives or corticosteroids may increase the risk of hypokalemia and cardiac effects. Use with QT-prolonging agents may enhance arrhythmogenic potential.
Missed dose
If a dose is missed, take it as soon as remembered unless it is near the time of the next scheduled dose. Do not double the dose to catch up. Resume the regular dosing schedule. Consistent timing is advised to maintain stable plasma levels.
Overdose
Overdose may manifest as severe tachycardia, hypertension, hypokalemia, tremors, nausea, and cardiac arrhythmias. Symptoms of profound overdose may include cardiac arrest, metabolic acidosis, and hyperglycemia. Treatment is supportive and symptomatic: activated charcoal if ingestion was recent, cardiovascular monitoring, potassium supplementation, and selective beta-blockers (e.g., metoprolol) may be considered under strict medical supervision. Avoid non-selective beta-blockers due to risk of bronchospasm.
Storage
Store at room temperature (15–30°C), protected from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Discard any unused medication appropriately according to local regulations.
Disclaimer
This information is intended for educational purposes and professional reference only. It is not a substitute for medical advice, diagnosis, or treatment. Clenbuterol is a prescription medication in most countries and should only be used under the supervision of a qualified healthcare provider. Unauthorized possession, distribution, or use may be illegal and is associated with serious health risks. The off-label uses described are not endorsed by regulatory agencies.
Reviews
“As a pulmonologist, I’ve found clenbuterol to be effective in certain cases of refractory asthma where other bronchodilators have failed. However, its side effect profile demands careful patient selection and monitoring.” — Dr. Elena Rostova, MD
“Used responsibly and under medical guidance, clenbuterol can offer significant relief for respiratory distress. Its potential for misuse, however, cannot be overstated.” — Clinical Pharmacist Review
“The metabolic effects are often exaggerated in non-medical circles. In a controlled setting, it has limited but specific applications. Patient education is crucial.” — Endocrinology Today